Clinical Microbiology Newsletter
Volume 32, Issue 5 , Pages 33-37, 1 March 2010

Code Sepsis: Rapid Methods To Diagnose Sepsis and Detect Hematopathogens:

Part I: The Impact and Attributes of Sepsis

  • Donna M. Wolk, MHA, Ph.D., D(ABMM)

      Affiliations

    • Corresponding Author InformationMailing address: Donna M. Wolk, MHA, Ph.D., D(ABMM), Assistant Professor, Department of Pathology, University of Arizona, 1501 N. Campbell Ave., P.O. Box 245059, Tucson, AZ 85724-5059. Tel.: 520-626-3676. Fax:520-694-7329
  • ,
  • Albert B. Fiorello, M.D.

Department of Emergency Medicine, University of Arizona, Tucson, Arizona

Abstract 

Bloodstream infections are among the top causes of death in the United States, and substantial mortality is attributed to testing delays in determinating the microbial cause(s) and selection of the appropriate antibiotic. In this review, we summarize the human and financial impact of sepsis, as well as the predisposing factors, symptoms, and common modes of bacterial pathogenesis. We also detail important clinical and laboratory criteria for the diagnosis of sepsis and key aspects of the Surviving Sepsis Campaign Guidelines as they relate to diagnosis, therapy, and resuscitation from the septic event. Clinical laboratories must expand their understanding of the complexities related to diagnosing and treating sepsis in order to expand their role as productive members of interdisciplinary health care teams focused on improving survival from sepsis and limiting the financial impact that sepsis imposes on our health care systems.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Editor's Note: Part II of this article will appear in the March 15, 2010 issue of CMN, Volume 32, Number 6.

PII: S0196-4399(10)00007-3

doi:10.1016/j.clinmicnews.2010.02.001

Clinical Microbiology Newsletter
Volume 32, Issue 5 , Pages 33-37, 1 March 2010